PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Подборка полезной литературы – часть 2

Опубликовано 29 июня, 201930 июня, 2019 frozencat

An Introduction to Categorical Data Analysis

Categorical Data Analysis

Clinical Trials, Second Edition: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines

Randomization in clinical trials : theory and practice

Introduction to Statistical Methods for Clinical Trials

Introduction to Randomized Controlled Clinical Trials, Second Edition (Texts in Statistical Science Series)

Statistical Advances in the Biomedical Sciences: Clinical Trials, Epidemiology, Survival Analysis, and Bioinformatics (Wiley Series in Probability and Statistics)

Clinical Trials: A Practical Guide to Design, Analysis, and Reporting

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook and Computer Simulations

Basic Pharmacokinetics

Basic Pharmacokinetic Concepts and Some Clinical Applications

Using R and RStudio for Data Management, Statistical Analysis and Graphics

A Data Scientist’s Guide to Acquiring, Cleaning, and Managing Data in R

DAMA-DMBOK (2nd Edition): Data Management Body of Knowledge

 

Рубрики: Блог, Общее

Навигация по записям

Предыдущая запись: Протокол и отчет клинического исследования биоэквивалентности: шаблон
Следующая запись: ClinicalTrialUtilities: обзор

Свежие записи

  • Оценка данных вариации литературных источников для определения объема выборки клинических исследований биоэквивалентности
  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Галерея

DJI 0017
20180131 140107
20180814 160821
20170802 185217
20180814 165315
IMG-20170806-WA0045
  • CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Medication Health Fraud
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • FDA and Kratom
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Hiding in Plain Sight: 7-OH Products
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • FDA warns about heavy metal poisoning associated with certain unapproved ayurvedic drug products
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Fraudulent Products
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Public Meeting on the Reauthorization of the Biosimilar User Fee Act (BsUFA) - 12/03/2025
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-12-02 By FDA
  • Recently Issued Guidance Documents
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-02 By FDA
  • Labeling and Promotion Guidances
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-12-02 By FDA
  • Bioresearch Monitoring Information System (BMIS)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-02 By FDA
  • FDA Grand Rounds – Advancing Real-World Evidence in FDA Regulatory Decision Making - 12/11/2025
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-12-02 By FDA
  • Human medicines European public assessment report (EPAR): Kaletra, lopinavir,ritonavir, Date of authorisation: 19/03/2001, Revision: 65, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-12-02
  • Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Date of authorisation: 19/06/2015, Revision: 23, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-12-02
  • Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-12-02
Older posts
Тема: Scaffold от Danny Cooper.